Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Board/Management Information 2022

Jan 27, 2022

62616_rns_2022-01-27_1942c6bd-d23c-4888-97c6-b77ef34df9c9.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

January 27, 2022

The National Stock Exchange of India Limited

Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: STAR

The BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Scrip Code: 532531

Dear Sirs,

Sub: Intimation regarding rescheduling of Board Meeting pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015

We refer to our letter dated January 21, 2022, regarding intimation of the date of Board Meeting of the Company scheduled to be held on January 28, 2022, inter alia, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31, 2021.

Due to unavoidable circumstances, the said meeting has been rescheduled and will now be held on Thursday, February 10, 2022.

As per the provisions of the Company’s Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed and shall open after 48 hrs post declaration of financial results by the Company.

This is for your kind information and record purposes.

Thanks & Regards, For Strides Pharma Science Limited,

==> picture [115 x 51] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [84 x 82] intentionally omitted <==

==> picture [479 x 52] intentionally omitted <==